You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動 | 迪安診斷漲近6% 三款新型冠狀病毒檢測產品獲英國MHRA註冊
格隆匯 03-26 10:30
格隆匯3月26日丨迪安診斷(300244.SZ)一度漲逾7%,現漲幅收窄至5.99%,報24.58元,暫成交2.1億元,最新總市值152億元。迪安診斷昨晚公佈,公司全資子公司杭州迪安生物的三款新型冠狀病毒檢測產品於近日獲得了英國MHRA(中文譯名:英國藥品和健康產品管理局)的註冊。產品名稱為新冠核酸檢測試劑盒,新冠核酸提取試劑盒及新冠核酸提取儀。迪安生物上述產品獲得英國MHRA註冊,表明該系列產品符合歐盟相關要求,已經具備歐盟市場的准入條件,將進一步增強公司產品的綜合競爭力,為全球新冠肺炎疫情防控貢獻力量。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account